Medtech company behind home analysis of blood tests to enter stock exchange in Spring

A brand new Danish medtech company with 20 years of research and experience behind it is entering the stock exchange in March, where it wants to raise DKK 32 million (USD 4.7 million) to kickstart sales of a new product, which aims to make it easier to monitor and diagnose illlnesses.

Thomas Warthoe, CEO of Qlife, is taking the company to the Swedish stock exchange next year. Photo: Photo: Qlife

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles